Meniere Disease Overview
Learn About Meniere Disease
Ménière disease is a disorder of the inner ear that affects balance and hearing. This condition is characterized by sudden episodes of extreme dizziness (vertigo), a roaring sound in the ears (tinnitus), a feeling of pressure or fullness in the ears, and fluctuations in hearing. Episodes are often associated with nausea and vomiting, and they can severely disrupt activities of daily living.
The cause of Ménière disease is unknown, although it probably results from a combination of environmental and genetic factors.
The prevalence of Ménière disease varies in different geographic regions and ethnic groups. It appears to be more common in people of European descent than in those with other backgrounds. In the United States, there are an estimated 615,000 people with Ménière disease, and more than 45,000 new cases are diagnosed each year.
Most cases of Ménière disease are sporadic, which means they occur in people with no history of the disorder in their family. A small percentage of all cases have been reported to run in families.
University Medical Associates Of The Medical University Of South Carol
Habib Rizk is an Otolaryngologist in Charleston, South Carolina. Dr. Rizk is rated as an Elite provider by MediFind in the treatment of Meniere Disease. His top areas of expertise are Meniere Disease, Vertigo, Benign Paroxysmal Positional Vertigo, Infant Hearing Loss, and Laryngectomy. Dr. Rizk is currently accepting new patients.
Pts
Jose Escamez-Lopez practices in Granada, Spain. Mr. Escamez-Lopez is rated as an Elite expert by MediFind in the treatment of Meniere Disease. His top areas of expertise are Meniere Disease, Tinnitus, Vertigo, and Hearing Loss.
Faculty Physicians And Surgeons Of Llusm
Steven Rauch is an Otolaryngologist and a General Surgeon in Rancho Cucamonga, California. Dr. Rauch is rated as an Elite provider by MediFind in the treatment of Meniere Disease. His top areas of expertise are Meniere Disease, Vertigo, Benign Paroxysmal Positional Vertigo, and Nonsyndromic Hearing Loss. Dr. Rauch is currently accepting new patients.
Summary: Study of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermittent use.
Summary: A Phase II randomized, placebo controlled study design of anakinra (Kineret) in corticosteroid-resistant or intolerant Meniere's disease (CR-MD)and corticosteroid-resistant or intolerant autoimmune inner ear disease (CR-AIED) patients. Patients will be randomized by a 2:1 allocation to anakinra or placebo for 42 continuous days. After day 42, a second placebo-controlled period will begin for an ad...
Published Date: October 01, 2017
Published By: National Institutes of Health